Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology
ClinicalTrials.gov Identifier:
NCT00027963
First received: December 7, 2001
Last updated: July 1, 2016
Last verified: July 2016